MedPath

The effect of low-level laser acupuncture for primary dysmenorrhea in wome

Not Applicable
Conditions
Primary dysmenorrhea
Alternative and Complementary Medicine - Other alternative and complementary medicine
Reproductive Health and Childbirth - Menstruation and menopause
Registration Number
ACTRN12622000350729
Lead Sponsor
Edith Cowan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

1) Diagnosed with PD by the general practitioner (GP) based on a history of cramping pain during menstruation and physical examination with normal findings; 2) aged between 18 and 40 years; 3) with regular menstrual cycles (28±7 days) for the past three months; 4) course of dysmenorrhea at least six months; 5) experiencing an average menstrual pain visual analog scale (VAS) score of more than 4cm during screening; 6) ability to read and write in English; 7) agree to complete the questionnaires; (8) willing and capable of giving consent.

Exclusion Criteria

1) Secondary dysmenorrhea; 2) allergic to light; 3) uncontrolled psychiatric disorders, or other symptoms of unknown cause; 4) women in lactation, or those planning to become pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recruitment and completion rate: the number of participants referred, eligible, enrolled, withdrawn, and completed will be recorded. The recruitment rate will be audited by dividing the number of consented people by the number of eligibilities, while the completion rate will be evaluated by dividing the number of completion by the number of enrollment.[This outcome will be assessed at post-intervention (after completion of 12 treatment sessions) (T1).];Participant compliance and adherence: participants' sessions attendance, completed sessions, missed sessions, and arranging appointments will be recorded via observational sheets.[This outcome will be assessed during intervention (both cycle 1 and cycle 2).];Non-pharmacological therapy preference in the past three months via study-specific online surveys.[This outcome will be assessed at baseline (T0).]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath